Literature DB >> 12609978

Mechanism of mitosis-specific activation of MEK1.

Angus Harding1, Nichole Giles, Andrew Burgess, John F Hancock, Brian G Gabrielli.   

Abstract

Activation of cyclin B-Cdc2 is an absolute requirement for entry into mitosis, but other protein kinase pathways that also have mitotic functions are activated during G(2)/M progression. The MAPK cascade has well established roles in entry and exit from mitosis in Xenopus, but relatively little is known about the regulation and function of this pathway in mammalian mitosis. Here we report a detailed analysis of the activity of all components of the Ras/Raf/MEK/ERK pathway in HeLa cells during normal G(2)/M. The focus of this pathway is the dramatic activation of an endomembrane-associated MEK1 without the corresponding activation of the MEK substrate ERK. This is because of the uncoupling of MEK1 activation from ERK activation. The mechanism of this uncoupling involves the cyclin B-Cdc2-dependent proteolytic cleavage of the N-terminal ERK-binding domain of MEK1 and the phosphorylation of Thr(286). These results demonstrate that cyclin B-Cdc2 activity regulates signaling through the MAPK pathway in mitosis.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12609978     DOI: 10.1074/jbc.M301015200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  19 in total

Review 1.  Phosphorylation state-specific antibodies: applications in investigative and diagnostic pathology.

Authors:  James W Mandell
Journal:  Am J Pathol       Date:  2003-11       Impact factor: 4.307

2.  MEK1 inactivates Myt1 to regulate Golgi membrane fragmentation and mitotic entry in mammalian cells.

Authors:  Julien Villeneuve; Margherita Scarpa; Maria Ortega-Bellido; Vivek Malhotra
Journal:  EMBO J       Date:  2012-12-14       Impact factor: 11.598

3.  Global functional analysis of nucleophosmin in Taxol response, cancer, chromatin regulation, and ribosomal DNA transcription.

Authors:  Daniel T Bergstralh; Brian J Conti; Chris B Moore; W June Brickey; Debra J Taxman; Jenny P-Y Ting
Journal:  Exp Cell Res       Date:  2006-09-26       Impact factor: 3.905

4.  Mitogen-activated protein/extracellular signal-regulated kinase kinase 1act/tubulin interaction is an important determinant of mitotic stability in cultured HT1080 human fibrosarcoma cells.

Authors:  Jia-Ning Cao; Norazizah Shafee; Larry Vickery; Stefan Kaluz; Ning Ru; Eric J Stanbridge
Journal:  Cancer Res       Date:  2010-06-22       Impact factor: 12.701

5.  Mitogen-activated protein kinase kinase 1-dependent Golgi unlinking occurs in G2 phase and promotes the G2/M cell cycle transition.

Authors:  Timothy N Feinstein; Adam D Linstedt
Journal:  Mol Biol Cell       Date:  2006-12-20       Impact factor: 4.138

6.  Nucleophosmin and nucleolin regulate K-Ras plasma membrane interactions and MAPK signal transduction.

Authors:  Kerry L Inder; Chiyan Lau; Dorothy Loo; Natasha Chaudhary; Andrew Goodall; Sally Martin; Alun Jones; Dharini van der Hoeven; Robert G Parton; Michelle M Hill; John F Hancock
Journal:  J Biol Chem       Date:  2009-08-06       Impact factor: 5.157

7.  Extracellular signal-regulated kinase 1/2 activity is not required in mammalian cells during late G2 for timely entry into or exit from mitosis.

Authors:  Mio Shinohara; Alexei V Mikhailov; Julio A Aguirre-Ghiso; Conly L Rieder
Journal:  Mol Biol Cell       Date:  2006-10-11       Impact factor: 4.138

8.  TRPC1 protein channel is major regulator of epidermal growth factor receptor signaling.

Authors:  Nicolas Tajeddine; Philippe Gailly
Journal:  J Biol Chem       Date:  2012-03-26       Impact factor: 5.157

9.  RSK promotes G2/M transition through activating phosphorylation of Cdc25A and Cdc25B.

Authors:  C F Wu; S Liu; Y-C Lee; R Wang; S Sun; F Yin; W G Bornmann; L-Y Yu-Lee; G E Gallick; W Zhang; S-H Lin; J Kuang
Journal:  Oncogene       Date:  2013-05-27       Impact factor: 9.867

10.  Phosphorylation regulates nucleophosmin targeting to the centrosome during mitosis as detected by cross-reactive phosphorylation-specific MKK1/MKK2 antibodies.

Authors:  Hyukjin Cha; Chad Hancock; Surabhi Dangi; Dony Maiguel; France Carrier; Paul Shapiro
Journal:  Biochem J       Date:  2004-03-15       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.